Robert G. Kramer
2018
In 2018, Robert G. Kramer earned a total compensation of $2.4M as President and Chief Executive Officer at Emergent BioSolutions, a 40% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $538,807 |
|---|---|
| Option Awards | $649,980 |
| Salary | $549,047 |
| Stock Awards | $649,930 |
| Other | $8,983 |
| Total | $2,396,747 |
Kramer received $650K in option awards, accounting for 27% of the total pay in 2018.
Kramer also received $538.8K in non-equity incentive plan, $549K in salary, $649.9K in stock awards and $9K in other compensation.
Rankings
In 2018, Robert G. Kramer's compensation ranked 4,854th out of 14,244 executives tracked by ExecPay. In other words, Kramer earned more than 65.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,854 out of 14,244 | 66th |
Division Manufacturing | 1,821 out of 5,765 | 68th |
Major group Chemicals And Allied Products | 664 out of 2,128 | 69th |
Industry group Drugs | 558 out of 1,817 | 69th |
Industry Pharmaceutical Preparations | 430 out of 1,391 | 69th |
Source: SEC filing on April 9, 2020.
Kramer's colleagues
We found six more compensation records of executives who worked with Robert G. Kramer at Emergent BioSolutions in 2018.
2018
Daniel Abdun-Nabi
Emergent BioSolutions
Chief Executive Officer
2018
Fuad El-Hibri
Emergent BioSolutions
Chairman
2018
Robert Kramer
Emergent BioSolutions
Chief Executive Officer
2018
Atul Saran
Emergent BioSolutions
General Counsel
2018
Adam Havey
Emergent BioSolutions
Executive Vice President, Business Operations
2018
Richard Lindahl
Emergent BioSolutions